Thyroid cancer patients who perceive no choice about radioactive iodine report lower decision satisfaction

Diabetes, polyarticular gout, prior opioid use tied to increased risk for opioid prescription at discharge

There are a lot of direct to consumer ads on TV these days. There is a lot of cultural diversity in the patients portrayed, and that lends itself to the assumption that these medications have the same effects across all racial segments. When you look deeper into the studies you …

Claims of improved cardiovascular outcomes from GLP-1 agonists and SGLT2 inhibitors not proven significant for black patients.

There is currently a huge unmet need for non-insulin add on therapy in type 1 diabetes, but are SGLT inhibitors the right drug for the job?

The influence of diabetes during pregnancy and the risk of autism.

Findings also revealed low use of statins among patients with chronic kidney disease

Have you ever heard the old saying; “if it looks like a duck and quacks like a duck, then it must be a duck”? Well, this week Kassey James, our Pharm.D. Candidate from LECOM School of Pharmacy, brings us an article that proves that this is not always true. She …

I had the pleasure of working with an elderly gentleman who was living alone. When he switched from insulin pens to a vial and syringe due to his insurance, his numbers started to increase into the 400’s and 500’s. He was feeling weak and lethargic but fortunately was able to pull …

The PIONEER 5 study discusses the safety and efficacy of the first oral GLP-1 receptor agonist, a potential substitute to injections.